The overexpression of APOBEC3B has been demonstrated to induce TP53 gene mutation, which has been shown to significantly promote tumor cell proliferation, migration, chemotherapy resistance and recurrence through the p53 pathway (39, 40). Here, TP53 is linked to neoplasm.